产品中心 抗体 其他一抗

所有图片(1/1)

WDR5 Recombinant Rabbit mAb (S-4143-43)

WD repeat-containing protein 5,BMP2-induced 3-kb gene protein,WD repeat-containing protein BIG-3,Big,Big3,Wdr5

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6981
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    WDR5
  • 分子别名

    WD repeat-containing protein 5; BMP2-induced 3-kb gene protein; WD repeat-containing protein BIG-3; Big; Big3; Wdr5
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Nucleus
  • Accession

    P61965
  • 克隆号

    S-4143-43
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Ms
  • 阳性样本

    C2C12, NIH/3T3, mouse spleen, mouse colon
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000-1:2000 Ms
背景介绍
  • WDR5 (WD repeat-containing protein 5) is a highly conserved core subunit of the mixed-lineage leukemia (MLL/SET1) family of histone H3 lysine 4 (H3K4) methyltransferase complexes, playing a pivotal role in epigenetic regulation and gene transcription. Structurally characterized by its seven-bladed β-propeller domain formed by WD40 repeats, WDR5 serves as a critical scaffold that stabilizes the MLL complex and facilitates its interaction with specific target proteins, including the recognition of arginine-methylated histone tails and non-histone substrates. Beyond its canonical function in promoting H3K4 methylationa hallmark of active transcriptionWDR5 is implicated in diverse cellular processes such as cell cycle progression, embryonic development, and stem cell pluripotency maintenance. Its dysregulation and overexpression are frequently observed in various malignancies, particularly acute leukemias and solid tumors, where it acts as an oncogenic driver by sustaining the expression of key proliferative genes like MYC, thereby making WDR5 a promising therapeutic target for cancer treatment through the development of specific small-molecule inhibitors that disrupt its protein-protein interactions.

  • 免疫印迹

    • WB result of WDR5 Recombinant Rabbit mAb
      Primary antibody: WDR5 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: C2C12 whole cell lysate 20 µg
      Lane 2: NIH/3T3 whole cell lysate 20 µg
      Lane 3: mouse spleen lysate 20 µg
      Lane 4: mouse colon lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 37 kDa
      Observed MW: 39 kDa

评论(0)